![Pieter B. M. W. M. Timmermans](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Pieter B. M. W. M. Timmermans
Chief Tech/Sci/R&D Officer at Kosan Biosciences, Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
David Reese | M | 61 | 19 years | |
Peter Davis | M | 79 |
Kosan Biosciences, Inc.
![]() Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 26 years |
Pamela Sarah Cohen | M | - |
Kosan Biosciences, Inc.
![]() Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
William Rieflin | M | 64 |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 8 years |
Daniel V. Santi | M | 82 |
Kosan Biosciences, Inc.
![]() Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | - |
Steven McKnight | M | 75 |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 13 years |
Carla Daniel | F | - |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 6 years |
Helen Kim | F | 61 |
Kosan Biosciences, Inc.
![]() Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 1 years |
Chaitan Khosla | M | 59 |
Kosan Biosciences, Inc.
![]() Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 13 years |
Andrew Perlman | M | 76 |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 11 years |
Sean B. W. Martin | M | 61 | - | |
David Louis Johnson | M | 70 |
Kosan Biosciences, Inc.
![]() Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | - |
Stephanie Wong | F | 50 |
Kosan Biosciences, Inc.
![]() Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 7 years |
Cynthia Patton | F | 62 | 15 years | |
Susan Lundeen Smuck | F | 57 | 12 years | |
Jane M. Green | M | - |
Kosan Biosciences, Inc.
![]() Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 1 years |
Jolanda Grob | F | 51 | 4 years | |
Stephen Shuttleworth | M | - |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 3 years |
Timothy Hoey | M | 65 | - | |
Fanesca Young | M | - | 2 years | |
Mike Nanfito | M | - | 4 years | |
Jason Chen | M | - | 2 years | |
David A. Boyden | M | 63 | 13 years | |
Hui Tian | M | - |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 5 years |
Corinne Nevinny | F | 64 |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 5 years |
Dung Thai | M | - | - | |
Brandon Smith | M | 50 | 7 years | |
Krishnan Mahesh /davita/ | - | - | 5 years | |
Steve Young | M | 55 |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 3 years |
Julia C. Owens | M | 51 |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 5 years |
Mark A. Schlossberg | M | 63 | 7 years | |
Reshma Kewalramani | M | 51 | 13 years | |
Vimal Srivastava | M | 58 | 3 years | |
Nacer E. Dean Abrouk | M | - | 4 years | |
Riccardo Perfetti | M | 64 | 3 years | |
Winston Kung | M | 48 | 3 years | |
Robert Goeltz | M | 51 |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 2 years |
Jason Shandell | M | 50 | 1 years | |
Sunita Zalani | M | - | 8 years | |
Eric Grinstead | M | 66 | 7 years | |
Christopher T. Walsh | M | 80 |
Kosan Biosciences, Inc.
![]() Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 12 years |
Amit Munshi | M | 56 | 8 years | |
Craig Saxton | M | 81 |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 3 years |
Charles R. Bradley | M | - | 5 years | |
Gary Titus | M | 64 |
Kosan Biosciences, Inc.
![]() Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 2 years |
Alan Colowick | M | 61 | 6 years | |
Kevan E. Clemens | M | 80 |
Kosan Biosciences, Inc.
![]() Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 3 years |
Peter J. Licari | M | 60 |
Kosan Biosciences, Inc.
![]() Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 10 years |
Jonathan Wright | M | - |
Kosan Biosciences, Inc.
![]() Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 1 years |
Charles Homcy | M | 75 |
Kosan Biosciences, Inc.
![]() Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 5 years |
David Goeddel | M | 72 | 2 years | |
Terry Rosen | M | 65 | 9 years | |
Jean Deleage | M | 83 |
Kosan Biosciences, Inc.
![]() Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | - |
Casey C. Case | M | - |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 4 years |
Robert G. Johnson | M | 72 |
Kosan Biosciences, Inc.
![]() Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 8 years |
Susan M. Kanaya | F | 61 |
Kosan Biosciences, Inc.
![]() Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 6 years |
John McLaughlin | M | 72 |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 2 years |
David Myles | M | 62 |
Kosan Biosciences, Inc.
![]() Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 1 years |
Bruce Chabner | M | 83 |
Kosan Biosciences, Inc.
![]() Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 7 years |
Marshall P. Levine | M | - |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 1 years |
Yasunori Kaneko | M | 69 |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 6 years |
Camille Samuels | F | 52 |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 2 years |
Dorian L. Rinella | F | - |
Kosan Biosciences, Inc.
![]() Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 1 years |
Mike Rothe | M | - |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 5 years |
Patrick Baeuerle | M | 66 |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 2 years |
Robert J. Stagg | M | - |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 2 years |
Karl G. Trass | M | 64 |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 2 years |
Robert L. de Jager | M | 82 |
Kosan Biosciences, Inc.
![]() Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 1 years |
Keith Leonard | M | 62 | 13 years | |
Jean-Frédéric Viret | M | 58 |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 2 years |
Valerie Pierce | F | 61 |
Tularik, Inc.
![]() Tularik, Inc. Miscellaneous Commercial ServicesCommercial Services Tularik, Inc. is engaged in the discovery and development of a broad range of novel and superior orally available medicines that act through the regulation of gene expression. Tularik's scientific platform is focused on three therapeutic areas: cancer, inflammation and metabolic disease. The company was founded in 1991 and is headquartered in South San Francisco, CA. | 4 years |
Rolf K. Hoffmann | M | 64 | 12 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 72 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Pieter B. M. W. M. Timmermans
- Personal Network